INS and type 2 diabetes mellitus: Incidence and severity of hypoglycemia episodes per participant during the 24-week GEMINI-T2Da study. Episodes were categorized by level: mild (3.0‐3.9 mmol/L), moderate (<3.0 mmol/L), and severe (requiring external assistance). Data highlight an increase in mild hypoglycemia episodes from weeks 0‐12 to weeks 13‐24. The study was conducted in 25 adults with insulin-treated type 2 diabetes using a web-based telehealth platform at the Singapore General Hospital from September 2020 to May 2022.